Coronavirus, from Plasma an anti Covid-19 treatment
Kedrion’s commitment to find a treatment from convalescent patient plasma
Kedrion Biopharma supports “Words in Hemophilia: Towards Patient Engagement”
The project will be developed by the EngageMinds Hub Research Center of the Catholic University of the Sacred Heart
From Italy to Albania: Kedrion supports the humanitarian donation of Factor VIII
An initiative which is a testimony to the close relationship between our two Countries in times of difficulty
Coronavirus, Kedrion supports home delivery of its hemophilia products
The home delivery program offered by Domedica is called #KoalaACasaTua
Kedrion Statement on the novel Coronavirus
In accordance with international, national and local authority guidelines, Kedrion has acted immediately in dealing with the epidemiological emergency linked to the spread of the novel Coronavirus, and has taken all necessary measures to safeguard the health and safety of its employees and guarantee continuation of business activities. Paolo Marcucci, Chairman & CEO has stated:
Letter to patient associations and scientific organizations
Communication from Paolo Marcucci, Chairman & CEO of Kedrion
The Sant’Antimo site: AIFA gives the go-ahead for the use of the new QC laboratories
An important step in consolidating the role of the Campania site within Kedrion’s production system
Kedrion in support of young researchers, the “Guelfo Marcucci” Awards ceremony in Milan
Two scholarships awarded to young researchers in the field of non-oncological hematology
Sant’Antimo site: first phase of investement completed
Opening of the new Quality Control and R&D laboratories
Kedrion to fund an innovative project for the treatment of Hemophilia A
INFOREC wins the Università di Pisa’s PoC grant. Chancellor’s office announces winner on Friday, July 26
